Reactive arthritis screening: Difference between revisions
Jump to navigation
Jump to search
m Categories |
No edit summary |
||
(One intermediate revision by one other user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Reactive arthritis}} | {{Reactive arthritis}} | ||
{{CMG}} | {{CMG}};{{AE}}{{Akshun}} | ||
==Overview== | ==Overview== | ||
There is insufficient evidence to recommend routine [[Screening (medicine)|screening]] for reactive arthritis. | |||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine [[Screening (medicine)|screening]] for reactive arthritis. | |||
==References== | ==References== |
Latest revision as of 03:32, 12 April 2018
Reactive arthritis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Reactive arthritis screening On the Web |
American Roentgen Ray Society Images of Reactive arthritis screening |
Risk calculators and risk factors forReactive arthritis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Akshun Kalia M.B.B.S.[2]
Overview
There is insufficient evidence to recommend routine screening for reactive arthritis.
Screening
There is insufficient evidence to recommend routine screening for reactive arthritis.